Global Non-Benzodiazepines Market Growth 2024-2030

Global Non-Benzodiazepines Market Growth 2024-2030

Non-benzodiazepines are a relatively new class of hypnotics

The global Non-Benzodiazepines market size is projected to grow from US$ 635.9 million in 2023 to US$ 1445.6 million in 2030; it is expected to grow at a CAGR of 12.4% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Non-Benzodiazepines Industry Forecast” looks at past sales and reviews total world Non-Benzodiazepines sales in 2023, providing a comprehensive analysis by region and market sector of projected Non-Benzodiazepines sales for 2024 through 2030. With Non-Benzodiazepines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Benzodiazepines industry.

This Insight Report provides a comprehensive analysis of the global Non-Benzodiazepines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Benzodiazepines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Benzodiazepines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Benzodiazepines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Benzodiazepines.

United States market for Non-Benzodiazepines is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Non-Benzodiazepines is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Non-Benzodiazepines is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Non-Benzodiazepines players cover Pfizer, Teva Pharmaceuticals, Torrent Pharma, Accord Healthcare and Akorn, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-Benzodiazepines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Dexmedetomidine
Zolpidem
Eszopiclone
Zopiclone
other

Segmentation by application
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Teva Pharmaceuticals
Torrent Pharma
Accord Healthcare
Akorn
Apotex
Fresenius Kabi
Hikma
Mylan
Par Pharmaceuticals
Sandoz
Sun Pharma
WG Critical Care
Athenex
Chenxin Pharmaceutical
Huatai Chenguang Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Non-Benzodiazepines market?

What factors are driving Non-Benzodiazepines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Non-Benzodiazepines market opportunities vary by end market size?

How does Non-Benzodiazepines break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.